MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • CAS Search

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 15804-19-0
Formula C8H6N2O2MW 162.15Research-use catalog entryCOA/SDS by request

2,3-Dihydroxyquinoxaline

CAS Number: 15804-19-0

Sourcing & RFQ

Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.

Available options

Available Options

Package
1 kg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
100 g
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
25 g
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
5 g
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
500 g
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required

Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.

Loading RDKit molecule structure...
InChIKey: ABJFBJGGLJVMAQ-UHFFFAOYSA-NC8H6N2O2 | MW 162.15

Chemical Absolute Identifiers

CAS Number

15804-19-0

PubChem CID

27491

Molecular Formula

C8H6N2O2

Molecular Weight

162.15 g/mol

Exact Mass

162.042927

InChIKey

ABJFBJGGLJVMAQ-UHFFFAOYSA-N

IUPAC Name

1,4-dihydroquinoxaline-2,3-dione

SMILES String

C1=CC=C2C(=C1)NC(=O)C(=O)N2

Physical Properties

Water Solubility

24.3 mol/L

Show more physical data

Vapor Pressure

Estimated very low; unit not specified

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Catalog Facts

Structural features

2,3-Dihydroxyquinoxaline (CAS 15804-19-0) is listed in the Advanced Chemicals portfolio, with molecular formula C8H6N2O2 and molecular weight 162. 15 g/mol.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Intended for research building-block and synthetic chemistry workflows; structure-derived tags include nitrogen-containing heterocycle.

Documentation needs

COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.

Applications & Classification

Heterocyclic Building BlocksSynthetic ChemistryResearch intermediateCustom synthesis building blockResearch chemical sourcingCustom synthesis and catalog availability reviewCOA, SDS, pricing, and fulfillment workflow
Biological target reference

ChEMBL reports experimental activity evidence for: Glutamate receptor ionotropic, NMDA 1 (Rattus norvegicus) — 2 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

Glutamate receptor ionotropic, NMDA 1

Rattus norvegicus · SINGLE PROTEIN · 2 qualifying assays · 2 documents · best pChEMBL 5.01

Experimental evidence source: ChEMBL

Safety & Handling

Handling & Storage

  • Keep container tightly closed and dry.
  • Store in a well-ventilated place.

PPE

Respiratory protection if needed

First Aid

  • Do not give anything to an unconscious person.
  • Rinse mouth with water.

Stability / Reactivity

  • Reactivity and reaction stability.
  • Carbon monoxide, carbon dioxide, nitrogen oxides.

Disposal

  • Dispose of remaining and non-recyclable solutions to a licensed company.
  • Contact a professional institution with a waste disposal license to handle this substance.
Show additional safety reference fields

Fire Fighting

  • If necessary, wear a self-contained breathing apparatus for firefighting.

Accidental Release

  • Do not generate dust when collecting and disposing.
  • Sweep and shovel up.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Names & Synonyms / External Identifiers

Chemical Name

2,3-Dihydroxyquinoxaline

Names & Synonyms

2,3-Quinoxalinedione, 1,4-dihydro-Quinoxaline-2,3(1H,4H)-dioneQuinoxaline-2,3-diol2,3-QUINOXALINEDIOL1,4-Dihydro-2,3-quinoxalinedione
Show all synonyms
2,3(1H,4H)-QuinoxalinedioneQuinoxaline, 2,3-dihydroxy-1,2,3,4-tetrahydroquinoxaline-2,3-dione1,4-Dihydro-quinoxaline-2,3-dione1,3-quinoxalinedioneQuinoxaline,3-dihydroxy-2,3-Dihydroxyphenpiazinehydroxyquinoxalonepropaquizafop TP3dihydroxy quinoxaline2,3(1H, 4H)-Quinoxalinedione1,4-Dihydro quinoxaline-2,3-dione2(1H), 3(4H)-QUINOXALINEDIONE10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.1
External Identifiers
EC NUMBER: 239-901-0DSSTOX SUBSTANCE ID: DTXSID9065946CHEMBL ID: CHEMBL282672UNII: APO55IZ9E1WIKIDATA ID: Q21099569
Experimental Spectrum References
13C NMR Spectra1D NMR Spectra1H NMR SpectraATR-IR Spectra — Forensic Spectral ResearchFTIR SpectraRaman Spectra — Forensic Spectral Research
Literature & Patent References
DOI 10.1021/acs.jmedchem.2c01212Emerging Target-Directed Approaches for the Treatment and Diagnosis of Microbial Infections.PMID 36586133Emerging Target-Directed Approaches for the Treatment and Diagnosis of Microbial Infections.DOI 10.1016/j.ejmech.2019.111987Design, synthesis and biological evaluation of quinoxaline compounds as anti-HIV agents targeting reverse transcriptase enzyme.PMID 31893549Design, synthesis and biological evaluation of quinoxaline compounds as anti-HIV agents targeting reverse transcriptase enzyme.DOI 10.1016/j.bmcl.2019.03.022Novel allosteric covalent inhibitors of bifunctional Cryptosporidium hominis TS-DHFR from parasitic protozoa identified by virtual screening.DOI 10.1016/j.bmcl.2019.06.046Evaluation of quinoxaline compounds as ligands of a site adjacent to S2 (AS2) of cruzain.PMID 30929953Novel allosteric covalent inhibitors of bifunctional Cryptosporidium hominis TS-DHFR from parasitic protozoa identified by virtual screening.PMID 31257083Evaluation of quinoxaline compounds as ligands of a site adjacent to S2 (AS2) of cruzain.

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

  1. 1We review the CAS identity, quantity, and documentation request.
  2. 2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
  3. 3We review destination and shipment documentation needs when applicable.
  4. 4We follow up with a quotation or clarification request.

Text Reference Cues

Show non-linked catalog cues

Non-public related references

1,4-Dihydro-6-methylquinoxaline-2,3-dioneCAS 6309-61-1
6-Chloro-1,4-dihydro-2,3-quinoxalinedioneCAS 6639-79-8
3-Methylquinoxalin-2-olCAS 14003-34-0
2,3-Dihydroxy-6,7-dichloroquinoxalineCAS 25983-13-5
3,4-Dihydro-3-oxo-2-quinoxalinecarboxylic acidCAS 1204-75-7

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Related Catalog Entries

Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.

CAS 6309-61-11,4-Dihydro-6-methylquinoxaline-2,3-dioneCAS 6639-79-86-Chloro-1,4-dihydro-2,3-quinoxalinedioneCAS 14003-34-03-Methylquinoxalin-2-olCAS 25983-13-52,3-Dihydroxy-6,7-dichloroquinoxalineCAS 1204-75-73,4-Dihydro-3-oxo-2-quinoxalinecarboxylic acidCAS 61977-29-56-Chloro-3-hydroxy-1,2-benzisoxazoleCAS 1002310-00-0Tert-butyl 1-(2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethylcarbamateCAS 1005174-17-3(E)-3-(2-Propyl-6-(trifluoromethyl)pyridin-3-yl)acrylic acidCAS 1018125-49-92-(3-Cyclopropyl-6-ethyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acidCAS 1018128-07-8Isopropyl 4-chloro-2-methylquinoline-6-carboxylate

RFQ questions for CAS 15804-19-0

What are the key identifiers for 2,3-Dihydroxyquinoxaline (CAS 15804-19-0)?

2,3-Dihydroxyquinoxaline is identified by CAS 15804-19-0, with molecular formula C8H6N2O2, molecular weight 162.15, InChIKey ABJFBJGGLJVMAQ-UHFFFAOYSA-N.

Does CAS 15804-19-0 have reported biological target evidence?

ChEMBL contains qualifying experimental assay evidence associated with Glutamate receptor ionotropic, NMDA 1. These records do not establish therapeutic efficacy or clinical use.

Can I request a COA for CAS 15804-19-0?

Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.

Can I request supplier SDS for 2,3-Dihydroxyquinoxaline?

Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.

Is CAS 15804-19-0 available for quotation?

Availability, pack size, lead time, and pricing are confirmed through RFQ.

Can MolGraph support bulk sourcing or custom synthesis review?

Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.